IHH Healthcare, a prominent multinational healthcare provider, has announced a significant double-digit growth in its financial results for the second quarter of 2026. The Group’s core revenue rose by 19% year-on-year to RM6.9b, whilst core profit after tax and minority interest (PATMI), excluding exceptional items, surged by 30% to RM675m. This growth is attributed to increased patient volumes and a more complex case mix across its diversified portfolio.
The Group’s performance was bolstered by strong results in key regions. Malaysia experienced higher revenue intensity and inpatient admissions, alongside a double-digit increase in daycase volumes. Türkiye and Europe continued to see broad-based growth, driven by strong local and foreign patient demand, even with the addition of new beds at several hospitals. In India, the integration of Fortis Healthcare and Gleneagles India under a maintenance services agreement contributed to ongoing growth.
Singapore showed signs of recovery, with occupancy rates improving to 51% in Q2 and maintaining strong margins of 29%. The Group plans to introduce more competitive packages in collaboration with leading insurers to further boost volumes.
Despite global volatilities and the impact of a stronger Ringgit, IHH’s reported revenue increased by 12% to RM7b, and reported PATMI rose by 29% to RM573m. The Group remains focused on its multi-year transformation journey, aiming for a double-digit return on equity by 2028, supported by country-specific growth strategies and operational synergies.
